default author photo

Peter Richmond

The University of Western Australia

SCHOLARLY PAPERS

10

DOWNLOADS

1,148

TOTAL CITATIONS

1

Scholarly Papers (10)

Actions:
Email selected abstracts
1.

Impact and Effectiveness of Australia's 2025 Hybrid RSV Immunisation Program: Results from the PAEDS-FluCAN Network

Number of pages: 28 Posted: 12 Mar 2026
Ushma Wadia, Peter Richmond, Philip Britton, Jeremy P. Carr, Julia E. Clark, Nigel W. Crawford, Te-Yu Hung, Helen S. Marshall, Kristine Macartney, Nick Wood, Brendan McMullan, Hannah Moore, Paul Effler, Allen Cheng and Christopher Blyth
Perth Children's Hospital - Department of Infectious Diseases, The University of Western Australia, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Monash University, Queensland Children's Hospital - Infection Management Service, University of Melbourne - Infection and Immunity, Charles Darwin University - Menzies School of Health Research, University of Adelaide - Vaccinology and Immunology Research Trials Unit, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Sydney Children's Hospital - Department of Immunology and Infectious Diseases, The Kids Research Institute Australia, The University of Western Australia, Monash University and Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases
Downloads 378 (204,523)

Abstract:

Loading...

2.

The Platform Trial in COVID-19 Priming and BOOsting (PICOBOO): The Immunogenicity, Reactogenicity, and Safety of Licensed COVID-19 Vaccinations Administered as a Second Booster in BNT162b2 Primed Individuals Aged 18-<50 and 50-<70 Years Old

Number of pages: 39 Posted: 08 Jul 2024
Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen S. Marshall, Marie J. Estcourt, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Francesca L. Mordant, Suellen Nicholson, Natalie Cain, Rianne Brizuela, Saul N. Faust, Ruth B. Thornton, Anne McKenzie, Julie A. Marsh, Thomas Snelling and Peter Richmond
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Tasmania - School of Health Sciences and School of Medicine, Royal Melbourne Institute of Technology (RMIT University), University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney, Perth Children's Hospital - Department of Infectious Diseases, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne - Department of Microbiology and Immunology (DMI), Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Charles Darwin University - Menzies School of Health Research and The University of Western Australia
Downloads 117 (613,149)
Citation 1

Abstract:

Loading...

COVID-19, Booster Vaccines, Immunogenicity, adaptive platform trial, health policy.

3.

A Phase I, Double-Blind, Dose-Ranging, Randomised, Placebo-Controlled Trial to Study the Safety and Immunogenicity of a DNA-Based Vaccine Against COVID-19 (COVIGEN) in Healthy SARS-CoV-2 Vaccine-Naïve Participants Aged 18 to 59 Years Old

Number of pages: 38 Posted: 21 Mar 2024
Nick Wood, Ushma Wadia, Peter Richmond, Chris Argent, Helen S. Marshall, Kerrie J. Sandgren, Katie Tungatt, Gabriela Martins Costa Gomes, Will Asquith, Janette Taylor, Matthew V. O'Sullivan, Dominic Dwyer, Anita H.J. van den Biggelaar, Laurent Dapremont, Souad Mansouri, Pham Hong Thai and Anthony L. Cunningham
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, The University of Western Australia, Scientia Clinical Research Ltd, University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - Westmead Institute for Medical Research, The University of Sydney - NSW Health Pathology, The University of Sydney - Westmead Hospital, The University of Sydney - Sydney Infectious Diseases Institute, The University of Sydney - Westmead Hospital, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, Technovalia Pty. Ltd., Technovalia Pty. Ltd., BioNet-Asia Co Ltd and The University of Sydney - Westmead Institute for Medical Research
Downloads 115 (617,542)

Abstract:

Loading...

DNA, SARS-CoV-2, vaccine, neutralising antibody, COVID-19, safety, immunogenicity

4.

The Platform Trial in COVID-19 Priming and Boosting (PICOBOO): The Immunogenicity, Reactogenicity, and Safety of Different COVID-19 Vaccinations Administered as a Second Booster (Fourth Dose) in Azd1222 Primed Individuals Aged 50-<70 Years Old

Number of pages: 13 Posted: 07 May 2024
Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen S. Marshall, Marie J. Estcourt, Ushma Wadia, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Francesca L. Mordant, Suellen Nicholson, Saul N. Faust, Ruth B. Thornton, Anne McKenzie, Julie A. Marsh, Thomas Snelling and Peter Richmond
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Tasmania - School of Health Sciences and School of Medicine, Royal Melbourne Institute of Technology (RMIT University), University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney, Perth Children's Hospital - Department of Infectious Diseases, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne - WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne - Department of Microbiology and Immunology (DMI), Victorian Infectious Diseases Reference Laboratory, The Royal Melbourne Hospital, at The Peter Doherty Institute for Infection and Immunity, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Charles Darwin University - Menzies School of Health Research and The University of Western Australia
Downloads 111 (640,165)

Abstract:

Loading...

Adaptive platform trial, COVID-19, vaccines, Bayesian, immunisation, policy

5.

Impact and Effectiveness of Australia’s 2025 hybrid RSV Immunisation Program: Results from the PAEDS-FluCAN Network

Number of pages: 28 Posted: 16 Mar 2026
Ushma Wadia, Peter Richmond, Philip Britton, Jeremy P. Carr, Julia E. Clark, Nigel W. Crawford, Te-Yu Hung, Helen S. Marshall, Kristine Macartney, Nick Wood, Brendan McMullan, Hannah Moore, Paul Effler, Allen C. Cheng and Christopher Blyth
Perth Children's Hospital - Department of Infectious Diseases, The University of Western Australia, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Monash University, Queensland Children's Hospital - Infection Management Service, University of Melbourne - Infection and Immunity, Charles Darwin University - Menzies School of Health Research, University of Adelaide - Vaccinology and Immunology Research Trials Unit, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Sydney Children's Hospital - Department of Immunology and Infectious Diseases, The Kids Research Institute Australia, The University of Western Australia, Monash University - Department of Infectious Diseases and Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases
Downloads 94 (837,727)

Abstract:

Loading...

RSV, maternal vaccine, RSV monoclonal antibodies, effectiveness, nirsevimab, children, hospitalisation, infant

6.

Respiratory Viral Testing Patterns within the Hospital Setting in Young Children Across Western Australia: A Population-Based Birth Cohort Study

Number of pages: 24 Posted: 15 May 2024
Belaynew Wasie Taye, Mohinder Sarna, Huong Le, Avram Levy, Cara Minney–Smith, Peter Richmond, Robert Menzies, Christopher C. Blyth and Hannah C. Moore
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, The University of Western Australia, Sanofi Vaccines, Australia and New Zealand, The University of Western Australia and Perth Children’s Hospital - Telethon Kids Institute
Downloads 90 (753,595)

Abstract:

Loading...

Respiratory virus, Within-hospital viral testing, Child, Respiratory virus-associated hospitalisation, Lower respiratory infection, Australia

7.

Estimating the Regional and Temporal Incidence of Respiratory Syncytial Virus and Influenza Hospitalisations in Young Australian Children: A Birth Cohort Study Using Predictive Modelling

Number of pages: 21 Posted: 27 Jan 2025
Belaynew Wasie Taye, Avram Levy, Mohinder Sarna, Cara Minney–Smith, Robert Menzies, Huong Le, Peter Richmond, Christopher C. Blyth and Hannah C. Moore
Perth Children’s Hospital - Telethon Kids Institute, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, Perth Children’s Hospital - Telethon Kids Institute, Queen Elizabeth II Medical Centre - PathWest Laboratory Medicine WA, Sanofi Vaccines, Australia and New Zealand, Perth Children’s Hospital - Telethon Kids Institute, The University of Western Australia, The University of Western Australia and Perth Children’s Hospital - Telethon Kids Institute
Downloads 81 (796,622)

Abstract:

Loading...

Predictive modelling, Under-ascertainment, Geographic variation, Cohort study, Respiratory virus infection, Children, Hospitalisation

8.

Clinical Predictors of Hypoxic Pneumonia in Children from the Eastern Highlands Province, Papua New Guinea

Number of pages: 33 Posted: 17 Oct 2023
Kathryn J. Britton, William Pomat, Joycelyn Sapura, John Kave, Birunu Nivio, Rebecca Ford, Wendy Kirarock, Hannah C. Moore, Lea-Ann S. Kirkham, Peter Richmond, Jocelyn Chan, Deborah Lehmann, Fiona M. Russell and Christopher Blyth
Perth Children’s Hospital - Telethon Kids Institute, Papua New Guinea Institute of Medical Research - Population Health and Demography Unit, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Papua New Guinea Institute of Medical Research, Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, The University of Western Australia, University of Melbourne - Murdoch Children's Research Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Melbourne - Murdoch Children's Research Institute and Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases
Downloads 74 (844,901)

Abstract:

Loading...

Pneumonia, Child, Hypoxaemia, Clinical signs, Papua New Guinea

9.

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): the reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults

Number of pages: 15 Posted: 22 Apr 2026
Charlie McLeod, Michael Dymock, Katie Flanagan, Magdalena Plebanski, Helen S. Marshall, Marie J. Estcourt, Christian Tjiam, Christopher Blyth, Kanta Subbarao, Suellen Nicholson, Saul N. Faust, Ushma Wadia, Ruth B. Thornton, Zoe Ellis, Phoebe Catherine May Williams, Anne McKenzie, Julie Marsh, Carly McCallum, George Salama, Thomas Snelling and Peter Richmond
Perth Children’s Hospital - Telethon Kids Institute, Perth Children’s Hospital - Telethon Kids Institute, University of Tasmania - Launceston General Hospital, Royal Melbourne Institute of Technology (RMIT University), University of Adelaide - Vaccinology and Immunology Research Trials Unit, The University of Sydney, The Kids Research Institute Australia, Perth Children’s Hospital - Wesfarmer's Centre for Vaccines and Infectious Diseases, University of Melbourne, affiliation not provided to SSRN, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Perth Children's Hospital - Department of Infectious Diseases, Perth Children’s Hospital - Telethon Kids Institute, The Kids Research Institute Australia, Peter MacCallum Cancer Centre - Department of Infectious Diseases, The Kids Research Institute Australia, Perth Children’s Hospital - Telethon Kids Institute, The Kids Research Institute Australia, The Kids Research Institute Australia, Charles Darwin University - Menzies School of Health Research and The University of Western Australia
Downloads 50 (1,109,210)

Abstract:

Loading...

COVID-19, vaccine, clinical trial, reactogenicity, safety.

10.

Understanding Motivation and Experience in Participating in a Paediatric Sars-Cov-2 Serosurvey, in Australia

Number of pages: 17 Posted: 12 Aug 2025
Archana Koirala, Shayal Artima Prasad, Philip Britton, Nick Wood, Peter Richmond, Brendan McMullan, Nigel W. Crawford, Helen S. Marshall, Laura Francis, Michelle Wills, Emma Leighton, Kristine Macartney and Katarzyna T. Bolsewicz
Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), National Centre for Immunisation Research and Surveillance, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS), The University of Western Australia, Sydney Children's Hospital - Department of Immunology and Infectious Diseases, University of Melbourne - Infection and Immunity, University of Adelaide - Vaccinology and Immunology Research Trials Unit, Royal Darwin Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS) and Children’s Hospital at Westmead - The National Centre for Immunisation Research and Surveillance (NCIRS)The University of Sydney, School of Public Health
Downloads 38 (1,222,651)

Abstract:

Loading...

SARS-CoV-2, covid-19, serosurvey, Qualitative, children, paediatric research